First Drug-Eluting Self-Expanding Covered Stent Demonstrates 95% Patency Through 6 Months; 100% Procedural Success and Zero 30-Day Device Related Adverse Events
SAN FRANCISCO, CA, UNITED STATES, October 27, 2025 /EINPresswire.com/ — Solaris …
October 27, 2025
First Drug-Eluting Self-Expanding Covered Stent Demonstrates 95% Patency Through 6 Months; 100% Procedural Success and Zero 30-Day Device Related Adverse Events
SAN FRANCISCO, CA, UNITED STATES, October 27, 2025 /EINPresswire.com/ — Solaris …
